Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2007 1
2008 2
2009 2
2010 1
2011 1
2012 3
2013 4
2014 6
2015 1
2017 2
2018 1
2024 1
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Real-World Outcomes in NPM1-Mutated Acute Myeloid Leukemia: The Impact of Measurable Residual Disease on Disease Relapse.
Tsirigotis P, Garofalaki M, Lazana I, Liga M, Gigantes S, Kopsaftopoulou A, Tziotziou E, Roumelioti A, Tsintziloni E, Hatzis S, Konstantellos I, Benetatos L, Barbarousi D, Tzenou T, Asimakopoulos JV, Karagiannidi A, Barakos G, Delimpasi S, Stoumbos D, Stamouli M, Plata E, Valera K, Giannouli S, Chatzidimitriou C, Gkolfinopoulou G, Siakantaris MP, Kotsopoulou M, Voulgarelis M, Chondropoulos S, Zina V, Gkirkas K, Kapsali E, Matsouka C, Vassilakopoulos TP, Spyridonidis A, Angelopoulou M, Baltadakis I. Tsirigotis P, et al. Among authors: tzenou t. Am J Hematol. 2026 Jul;101(7):1543-1553. doi: 10.1002/ajh.70322. Epub 2026 Apr 10. Am J Hematol. 2026. PMID: 41960888
EASIX and m-EASIX predict severe cytokine release syndrome and overall survival after CAR T-cell therapy.
Gavriilaki E, Tzannou I, Batsis I, Tsonis I, Liga M, Gkirkas K, Ximeri M, Dolgyras P, Bampali V, Evangelidis P, Bousiou Z, Vardi A, Demosthenous C, Stroggyli E, Bouzani M, Sagiadinou E, Mallouri D, Tzenou T, Sotiropoulos D, Gigantes S, Anagnostopoulos A, Karakasis D, Papadaki H, Tsirigotis P, Spyridonidis A, Vassilakopoulos T, Angelopoulou M, Sakellari I, Baltadakis I. Gavriilaki E, et al. Among authors: tzenou t. Blood Vessel Thromb Hemost. 2024 Aug 21;1(4):100025. doi: 10.1016/j.bvth.2024.100025. eCollection 2024 Dec. Blood Vessel Thromb Hemost. 2024. PMID: 40765934 Free PMC article. No abstract available.
Management strategies for CAR-T cell therapy-related toxicities: results from a survey in Greece.
Gavriilaki E, Tzannou I, Vardi A, Tsonis I, Liga M, Gkirkas K, Ximeri M, Bousiou Z, Bouzani M, Sagiadinou E, Dolgyras P, Kotsiou N, Bampali V, Mallouri D, Tzenou T, Batsis I, Sotiropoulos D, Gigantes S, Papadaki HA, Tsirigotis P, Spyridonidis A, Vassilakopoulos TP, Angelopoulou M, Baltadakis I, Sakellari I. Gavriilaki E, et al. Among authors: tzenou t. Front Med (Lausanne). 2025 May 30;12:1553966. doi: 10.3389/fmed.2025.1553966. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40520784 Free PMC article.
The Prognostic Impact of Additional Molecular and Cytogenetic Abnormalities on AML Patients with NPM1- and/or FLT3-ITD Mutations Receiving Intensive Chemotherapy: Real-World Data from the Greek Registry.
Lazana I, Papathanassiou M, Konstantellos I, Tzenou T, Kopsaftopoulou A, Liga M, Violaki V, Kyriazopoulou L, Gkirkas K, Papalexandri A, Plata E, Michalis E, Leonidopoulou T, Garofalaki M, Sioni A, Tziotziou I, Lalayanni C, Kiousiafes D, Vassilakopoulos TP, Kapsali E, Spyridonidis A, Baltadakis I, Angelopoulou M, Sakellari I, Tsirigotis P. Lazana I, et al. Among authors: tzenou t. Cancers (Basel). 2025 Feb 16;17(4):667. doi: 10.3390/cancers17040667. Cancers (Basel). 2025. PMID: 40002262 Free PMC article.
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy.
Baliakas P, Mattsson M, Hadzidimitriou A, Minga E, Agathangelidis A, Sutton LA, Scarfo L, Davis Z, Yan XJ, Plevova K, Sandberg Y, Vojdeman FJ, Tzenou T, Chu CC, Veronese S, Mansouri L, Smedby KE, Giudicelli V, Nguyen-Khac F, Panagiotidis P, Juliusson G, Anagnostopoulos A, Lefranc MP, Trentin L, Catherwood M, Montillo M, Niemann CU, Langerak AW, Pospisilova S, Stavroyianni N, Chiorazzi N, Oscier D, Jelinek DF, Shanafelt T, Darzentas N, Belessi C, Davi F, Ghia P, Rosenquist R, Stamatopoulos K. Baliakas P, et al. Among authors: tzenou t. Haematologica. 2018 Apr;103(4):e158-e161. doi: 10.3324/haematol.2017.182634. Epub 2017 Dec 21. Haematologica. 2018. PMID: 29269523 Free PMC article. No abstract available.
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.
Xochelli A, Baliakas P, Kavakiotis I, Agathangelidis A, Sutton LA, Minga E, Ntoufa S, Tausch E, Yan XJ, Shanafelt T, Plevova K, Boudjogra M, Rossi D, Davis Z, Navarro A, Sandberg Y, Vojdeman FJ, Scarfo L, Stavroyianni N, Sudarikov A, Veronese S, Tzenou T, Karan-Djurasevic T, Catherwood M, Kienle D, Chatzouli M, Facco M, Bahlo J, Pott C, Pedersen LB, Mansouri L, Smedby KE, Chu CC, Giudicelli V, Lefranc MP, Panagiotidis P, Juliusson G, Anagnostopoulos A, Vlahavas I, Antic D, Trentin L, Montillo M, Niemann C, Döhner H, Langerak AW, Pospisilova S, Hallek M, Campo E, Chiorazzi N, Maglaveras N, Oscier D, Gaidano G, Jelinek DF, Stilgenbauer S, Chouvarda I, Darzentas N, Belessi C, Davi F, Hadzidimitriou A, Rosenquist R, Ghia P, Stamatopoulos K. Xochelli A, et al. Among authors: tzenou t. Clin Cancer Res. 2017 Sep 1;23(17):5292-5301. doi: 10.1158/1078-0432.CCR-16-3100. Epub 2017 May 23. Clin Cancer Res. 2017. PMID: 28536306
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.
Baliakas P, Agathangelidis A, Hadzidimitriou A, Sutton LA, Minga E, Tsanousa A, Scarfò L, Davis Z, Yan XJ, Shanafelt T, Plevova K, Sandberg Y, Vojdeman FJ, Boudjogra M, Tzenou T, Chatzouli M, Chu CC, Veronese S, Gardiner A, Mansouri L, Smedby KE, Pedersen LB, Moreno D, Van Lom K, Giudicelli V, Francova HS, Nguyen-Khac F, Panagiotidis P, Juliusson G, Angelis L, Anagnostopoulos A, Lefranc MP, Facco M, Trentin L, Catherwood M, Montillo M, Geisler CH, Langerak AW, Pospisilova S, Chiorazzi N, Oscier D, Jelinek DF, Darzentas N, Belessi C, Davi F, Ghia P, Rosenquist R, Stamatopoulos K. Baliakas P, et al. Among authors: tzenou t. Blood. 2015 Jan 29;125(5):856-9. doi: 10.1182/blood-2014-09-600874. Epub 2014 Dec 17. Blood. 2015. PMID: 25634617 Free PMC article.
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study.
Baliakas P, Hadzidimitriou A, Sutton LA, Minga E, Agathangelidis A, Nichelatti M, Tsanousa A, Scarfò L, Davis Z, Yan XJ, Shanafelt T, Plevova K, Sandberg Y, Vojdeman FJ, Boudjogra M, Tzenou T, Chatzouli M, Chu CC, Veronese S, Gardiner A, Mansouri L, Smedby KE, Pedersen LB, van Lom K, Giudicelli V, Francova HS, Nguyen-Khac F, Panagiotidis P, Juliusson G, Angelis L, Anagnostopoulos A, Lefranc MP, Facco M, Trentin L, Catherwood M, Montillo M, Geisler CH, Langerak AW, Pospisilova S, Chiorazzi N, Oscier D, Jelinek DF, Darzentas N, Belessi C, Davi F, Rosenquist R, Ghia P, Stamatopoulos K. Baliakas P, et al. Among authors: tzenou t. Lancet Haematol. 2014 Nov;1(2):e74-84. doi: 10.1016/S2352-3026(14)00005-2. Epub 2014 Nov 3. Lancet Haematol. 2014. PMID: 27030157
26 results